DANAHER CORP /DE/
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Rothschild & Co Redburn raised its price target for Danaher to $220 from $205. HSBC also increased its target to $260 from $250. Danaher's stock is currently trading at $230.50, with a 5-day change of +0.33%.
Danaher partnered with NVIDIA to advance AI-driven autonomous science, combining their technologies for faster research. Rush and Endeavor Health plan to merge, creating a large academic health system. FedEx Europe launched a digital portal for managing temperature-controlled pharmaceutical shipments. Waters Corporation introduced AI Link to connect AI with lab instruments, streamlining research processes.
Analysts updated recommendations for several companies. Jefferies upgraded Msc Industrial to buy, raising its target to $135. Landesbank Baden-Württemberg downgraded Qiagen to hold, lifting its target to €46.50. JP Morgan initiated coverage on Skydance with a neutral rating and $9 target. Other notable changes include target adjustments for Carpenter Tech, Danaher, Dutch Bros, Enphase, Medpace, Moderna, Molina, PG&E, ServiceNow, Thermo Fisher, Ttm, and Western Digital.
Over the past 7 days, AlphAI's AI scored 16 news stories mentioning DHR (DANAHER CORP /DE/). Coverage has skewed bullish: 16 bullish, 0 neutral, and 0 bearish.
Recent DHR coverage spans financial news, technology and earnings.
In the last 30 days, DHR insiders filed 2 SEC Form 4 transactions — no purchases and 2 sales. The most active reporter was RALES MITCHELL P, Chairman of Exec. Committee, with 1 filing.
Analyst target raise suggests bullish outlook for Danaher.
Positive sentiment as the partnership could boost Danaher's AI instrument portfolio.
Higher target supports bullish sentiment.
Analyst upgrade suggests potential upside for DHR.
Analyst upgrade with higher target may attract buying interest.
AlphAI scores every news story that mentions DHR with an AI model for sentiment and relevance, and aggregates insider trades from DANAHER CORP /DE/'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Rothschild & Co Redburn raised its price target for Danaher to $220 from $205. HSBC also increased its target to $260 from $250. Danaher's stock is currently trading at $230.50, with a 5-day change of +0.33%.
1 min readDanaher partnered with NVIDIA to advance AI-driven autonomous science, combining their technologies for faster research. Rush and Endeavor Health plan to merge, creating a large academic health system. FedEx Europe launched a digital portal for managing temperature-controlled pharmaceutical shipments. Waters Corporation introduced AI Link to connect AI with lab instruments, streamlining research processes.
3 min readAnalysts updated recommendations for several companies. Jefferies upgraded Msc Industrial to buy, raising its target to $135. Landesbank Baden-Württemberg downgraded Qiagen to hold, lifting its target to €46.50. JP Morgan initiated coverage on Skydance with a neutral rating and $9 target. Other notable changes include target adjustments for Carpenter Tech, Danaher, Dutch Bros, Enphase, Medpace, Moderna, Molina, PG&E, ServiceNow, Thermo Fisher, Ttm, and Western Digital.
2 min readCitigroup maintained a Buy rating for Danaher Corporation (DHR) and raised its price target from $230 to $270, citing optimism about the company's growth prospects. Danaher's stock is currently trading at $229.23, with a GF Value™ of $236.37, indicating it is 3.0% undervalued. The company has a GF Score™ of 81/100, reflecting strong performance in profitability and momentum, but some concerns about financial strength.
2 min readBarclays maintained an Overweight rating on Danaher (DHR) and raised its price target to $260 from $255. Danaher's stock is currently trading at $232.34, which is 1.7% below its GF Value™ of $236.37. The company has a GF Score™ of 81/100, indicating strong overall performance. Insiders have sold $12.7M in shares over the last three months.
1 min readTD Cowen raised Danaher Corporation's (DHR) price target to $270 from $255, maintaining a 'Buy' rating. DHR is currently trading at $234.23, slightly below its GF Value™ of $236.37. The company has a GF Score™ of 81/100, indicating strong performance, and is held by 26 gurus, with 18 increasing their positions.
2 min readStifel raised Danaher (DHR) price target to $260 from $220, citing strong core growth and 5%+ organic growth potential. The stock trades at a P/E of 41.19. Danaher reported Q3 2026 earnings of $2.11 per share, beating estimates, but shares fell premarket on respiratory revenue concerns.
2 min readGoldman Sachs raised its price target for Danaher to $275 from $250. Barclays and TD Cowen also adjusted their targets to $260 and $270, respectively. Danaher's stock has shown recent gains, with a 5-day change of +4.29%.
1 min readDanaher's management projects core revenue growth, excluding respiratory products, of 4-5% through 2027. The company attributes this to operational discipline and higher-margin diagnostics and life sciences segments. CEO Julie Sawyer Montgomery emphasizes long-term growth potential for shareholders.
1 min readRoivant Sciences shares rose 4% after its drug Lisraya met primary goals in trials. Bloom Energy gained 6% ahead of earnings. Bitcoin-linked stocks rose with BTC. Alphabet shares fell 2% as OpenAI models will be available on Google Cloud. Meta Platforms gained 2% ahead of earnings. SpaceX shares rose 10% after reporting a 161% revenue jump. Netflix shares fell 5% after narrowing its 2026 revenue forecast. AT&T slid 6% despite an earnings beat. Capital One gained 4% on strong Q3 earnings.
3 min read
